<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01861327</url>
  </required_header>
  <id_info>
    <org_study_id>CO2</org_study_id>
    <nct_id>NCT01861327</nct_id>
  </id_info>
  <brief_title>The Use of Carbon Dioxide as a Contrast Media for Performing Endovascular Procedures</brief_title>
  <official_title>The Use of Carbon Dioxide as a Contrast Media for Performing Endovascular Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nelson Wolosker</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministério da Saúde</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Israelita Albert Einstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective randomized comparison between endovascular procedures performed with iodinated&#xD;
      contrast or carbon dioxide as intraarterial contrast.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      120 patients will undergo endovascular procedures: 40 for the treatment of lower limb&#xD;
      ischemia caused by aortoiliac stenosis classified according to the consensus for the&#xD;
      management of peripheral arterial disease (TASC) A or B with an indication for angioplasty as&#xD;
      the inclusion criteria; 40 for the treatment of lower limb ischemia due to stenosis&#xD;
      femoropopliteal TASC A or B with an indication of angioplasty as the inclusion criteria and&#xD;
      40 for the treatment of abdominal aortic aneurysm (AAA) with indication for endovascular&#xD;
      repair. Of these procedures, half chosen randomly by computerized simple random, will be&#xD;
      submitted to the endovascular procedure in question using only iodinated contrast and the&#xD;
      other half will be submitted to the endovascular procedure using carbon dioxide (CO2). There&#xD;
      will be no CO2 injection in the aortic arch or cerebral territory. The patient previously&#xD;
      evaluated at the Hospital Municipal Dr. Moses Deutsch will be referred to the operating room&#xD;
      of the Albert Einstein Hospital where it will be performed under general anesthesia with&#xD;
      intubation or blockage associated with sedation, and the same in the supine position&#xD;
      (DDH).The femoral artery will be punctured with Seldinger technique unilaterally or&#xD;
      bilaterally, according to the indication for the procedure. By using the guide wire will be&#xD;
      one or two sheaths inserted in a retrograde manner. Through the introducer, is manually&#xD;
      injected retrogradely 50 ml of CO 2, in obtaining images of the apparatus module CO2 Philips&#xD;
      mode subtraction angiography. In angioplasty for obstructive disease, with the module roadmap&#xD;
      will be held the passage of the guidewire through the stenotic region or occlusion, and&#xD;
      dilatation balloon angioplasty specific. After angioplasty, there will be a new injection of&#xD;
      contrast for the evaluation of partial results. As appropriate, will be held stent placement,&#xD;
      in which case there will be a last angiography with 50 ml of CO2. In endovascular repair of&#xD;
      abdominal aortic aneurysms, there will be a first injection of CO2 for the study of the neck&#xD;
      of the aneurysm and stent implantation. After the release of the entire stent, a new&#xD;
      angiography is performed by injection of CO2 for the control of surgical outcome. In all&#xD;
      procedures will be performed to measure pressure through the femoral sheath prior to&#xD;
      angioplasty, after angioplasty and stent after the placement. During the use of CO2 as&#xD;
      contrast medium, with questions at the trial of such factors as the extent of injury,&#xD;
      indication of repair, endoleak, leak, rupture or thrombosis by arteriography will be&#xD;
      performed by manual injection of iodinated contrast.Of course this amount of contrast is&#xD;
      measured.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Contrastation analysis of the arterial lumen on endovascular procedures using CO2 as contrast media.</measure>
    <time_frame>within 2 weeks of the procedure done we will analyze the quality of the images with CO2 and iodine contrast</time_frame>
    <description>image evaluated ranging from 1 (poor -when there was significant loss of definition in the vessels and/or collateral circulation which precluded the procedure), 2 (fair - when there was some loss of definition in the vessels and/or collateral circulation but not impossible to perform the procedure) and 3 (good - when there was good contrast in the vessels and collateral circulation).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical outcome: changes in the post-surgery ABI</measure>
    <time_frame>within 24h of the procedure</time_frame>
    <description>Identify changes in ankle-braquial index (ABI) after the procedures</description>
  </secondary_outcome>
  <other_outcome>
    <measure>post surgery creatinin clearance measure by the Cockcroft and Gault equation</measure>
    <time_frame>within 30 days of the procedure</time_frame>
  </other_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Critical Lower Limb Ischemia</condition>
  <condition>Abdominal Aortic Aneurysms</condition>
  <arm_group>
    <arm_group_label>lower limb angioplasty with CO2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lower limb angioplasty made with carbon dioxide as contrast media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lower limb angioplasty with Iodine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>lower limb angioplasty made with Iodine as contrast media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>aorto-iliac angioplasty with CO2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>aorto-iliac angioplasty made with carbon dioxide as contrast media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>aorto-iliac angioplasty with Iodine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>aorto-iliac angioplasty made with Iodine as contrast media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>endovascular AAA correction with CO2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>endovascular abdominal aortic aneurysm (AAA) correction made with carbon dioxide as contrast media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>endovascular AAA correction with Iodine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>endovascular abdominal aortic aneurysm (AAA) correction made with Iodine as contrast media</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CO2</intervention_name>
    <description>carbon dioxide (CO2) as arterial contrast media</description>
    <arm_group_label>aorto-iliac angioplasty with CO2</arm_group_label>
    <arm_group_label>endovascular AAA correction with CO2</arm_group_label>
    <arm_group_label>lower limb angioplasty with CO2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iodine contrast media</intervention_name>
    <description>Iodine as arterial contrast media</description>
    <arm_group_label>aorto-iliac angioplasty with Iodine</arm_group_label>
    <arm_group_label>endovascular AAA correction with Iodine</arm_group_label>
    <arm_group_label>lower limb angioplasty with Iodine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  critical lower limb ischemia resulting from arterial disease morphology TASC A or B or&#xD;
             abdominal aortic aneurysms with correction indication&#xD;
&#xD;
          -  Agreement and signing the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  exhibited severe chronic obstructive pulmonary disease (COPD)&#xD;
&#xD;
          -  kidney failure&#xD;
&#xD;
          -  heart failure&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  TASC C or D lesions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nelson Wolosker</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Israelita Albert Einstein</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Israelita Albert Einstein</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <study_first_submitted>February 26, 2013</study_first_submitted>
  <study_first_submitted_qc>May 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2013</study_first_posted>
  <last_update_submitted>February 23, 2017</last_update_submitted>
  <last_update_submitted_qc>February 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Israelita Albert Einstein</investigator_affiliation>
    <investigator_full_name>Nelson Wolosker</investigator_full_name>
    <investigator_title>MD, PHD</investigator_title>
  </responsible_party>
  <keyword>Carbon dioxide</keyword>
  <keyword>aortic aneurysm</keyword>
  <keyword>angioplasty</keyword>
  <keyword>Critical lower limb ischemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

